Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The link between chronic pain that affects millions of women and hormones that control the menstrual cycle and reproductive function is to be studied for the first time by researchers at the Nuffield Department of Obstetrics & Gynaecology.

Image courtesy of Shutterstock

The study is being run by the Nuffield Department of Obstetrics and Gynaecology with support from Oxford University Hospitals NHS Foundation Trust. It seeks to determine the extent to which hormone production is altered in women with chronic pain so they can be better diagnosed and treated.

The results will also help further research on whether hormones can be used to reduce chronic pain.

Read more (Nuffield Department of Obstretrics and Gynaecology website)

Study contact

Lisa Buck 

Phone: 01865 221120 

Mob: 07802 861 666

Email: lisa.buck@obs-gyn.ox.ac.uk  

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.